MIRA Pharmaceuticals, Inc.
MIRA
$0.96
-$0.01-1.24%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -149.34% | 44.34% | 9.08% | -3.84% | 58.54% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 772.20% | -20.15% | -19.05% | 74.89% | -90.53% |
| Change in Net Operating Assets | 65.14% | -158.69% | 11.64% | -529.23% | 116.61% |
| Cash from Operations | 37.12% | 40.45% | 7.43% | -55.31% | -74.40% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 101.44% |
| Issuance of Common Stock | 824.20% | 10.85% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -336.06% | -115.96% | -- | 100.00% |
| Cash from Financing | 881.03% | -4.90% | 103.65% | 113.99% | 313.87% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 382.51% | 44.69% | 32.50% | -51.47% | -3.62% |